Aegerion Pharmaceuticals, Inc. Logo

Email this page: News Release

FDA Approves Aegerion Pharmaceuticals' JUXTAPID(TM) (lomitapide) Capsules for Homozygous Familial Hypercholesterolemia (HoFH)

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Aegerion Pharmaceuticals, Inc. for any marketing purposes.

Send:       


 
This helps Aegerion Pharmaceuticals, Inc. prevent automated submissions.